to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology

[1]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[2]  K. Harada,et al.  Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study. , 2019, European urology.

[3]  Yan Guo,et al.  Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion. , 2019, Radiology.

[4]  B. Konety,et al.  FDG‐PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients , 2018, Clinical genitourinary cancer.

[5]  R. Breau,et al.  Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta‐analysis , 2018, BJU international.

[6]  Seong-Jang Kim,et al.  Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis , 2018, Oncology.

[7]  Adam T Froemming,et al.  ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder Cancer. , 2018, Journal of the American College of Radiology : JACR.

[8]  Seung Hyup Kim,et al.  The Diagnostic Performance of MRI for Detection of Lymph Node Metastasis in Bladder and Prostate Cancer: An Updated Systematic Review and Diagnostic Meta-Analysis. , 2018, AJR. American journal of roentgenology.

[9]  Jin Wang,et al.  The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis. , 2017, Radiology.

[10]  J. Cho,et al.  Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: A systematic review and meta-analysis. , 2017, European journal of radiology.

[11]  M. S. Heijden,et al.  FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy , 2017, International Urology and Nephrology.

[12]  Søren Høyer,et al.  Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up. , 2017, European urology focus.

[13]  J. Cheville,et al.  Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy. , 2017, Pathology.

[14]  Massimo Midiri,et al.  Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  Xuwei Hong,et al.  Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis , 2016, Oncotarget.

[16]  R. Chou,et al.  Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline. , 2016, The Journal of urology.

[17]  K. Joo,et al.  Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional Study , 2016, Yonsei medical journal.

[18]  F. Montorsi,et al.  Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  A. Rosenkrantz,et al.  Investigation of Multisequence Magnetic Resonance Imaging for Detection of Recurrent Tumor After Transurethral Resection for Bladder Cancer , 2016, Journal of computer assisted tomography.

[20]  H. Aboulkassem,et al.  Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy. , 2016, Clinical genitourinary cancer.

[21]  R. Weichselbaum,et al.  Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy. , 2016, International journal of radiation oncology, biology, physics.

[22]  P. Malmström,et al.  Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study , 2015, Scandinavian journal of urology.

[23]  K. Shimada,et al.  Exploration of risk factors predicting outcomes for primary T1 high‐grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long‐term follow‐up experience at a single institute , 2015, International journal of urology : official journal of the Japanese Urological Association.

[24]  J. Witjes,et al.  Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation , 2015, World Journal of Urology.

[25]  Jianfeng Xu,et al.  The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population , 2015, PloS one.

[26]  G. Dalbagni,et al.  BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: a prospective cohort outcomes study. , 2015, Urologic oncology.

[27]  H. G. van der Poel,et al.  Follow-up after cystectomy: regularly scheduled, risk adjusted, or symptom guided? Patterns of recurrence, relapse presentation, and survival after cystectomy. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[28]  Anirban P. Mitra,et al.  Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. , 2014, Urology.

[29]  D. Barocas,et al.  Predictors of outcome in bladder cancer. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[30]  Young Hwan Kim,et al.  MDCT urography for detecting recurrence after transurethral resection of bladder cancer: comparison of nephrographic phase with pyelographic phase. , 2014, AJR. American journal of roentgenology.

[31]  Y. Ko,et al.  Usefulness of Urine Cytology as a Routine Work-up in the Detection of Recurrence in Patients With Prior Non-Muscle-Invasive Bladder Cancer: Practicality and Cost-Effectiveness , 2014, Korean journal of urology.

[32]  A. Papavassiliou,et al.  Tumor size and T stage correlate independently with recurrence and progression in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant BCG , 2014, Tumor Biology.

[33]  T. Guzzo,et al.  Re-examination of the natural history of high-grade T1 bladder cancer using a large contemporary cohort. , 2014, International braz j urol : official journal of the Brazilian Society of Urology.

[34]  Yan Guo,et al.  Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection , 2014, Abdominal Imaging.

[35]  K. Nakagawa,et al.  Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression , 2014, BMC Urology.

[36]  B. Bochner,et al.  Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer. , 2013, The Journal of urology.

[37]  J. Cheville,et al.  Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis. , 2013, The Journal of urology.

[38]  A. Zlotta,et al.  Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols , 2013, World Journal of Urology.

[39]  J. Cheville,et al.  Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis , 2012, World Journal of Urology.

[40]  E. Kikuchi,et al.  Prognostic significance of Bacillus Calmette‐Guérin failure classification in non‐muscle‐invasive bladder cancer , 2012, BJU international.

[41]  J. Cheville,et al.  The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. , 2012, The Journal of urology.

[42]  R. Coleman,et al.  Impact of 18F-FDG PET Used After Initial Treatment of Cancer: Comparison of the National Oncologic PET Registry 2006 and 2009 Cohorts , 2012, The Journal of Nuclear Medicine.

[43]  A. Skolarikos,et al.  Accuracy of modern ultrasonographic techniques in the follow up of patients with superficial bladder carcinoma. , 2011, Medical ultrasonography.

[44]  Eiji Kikuchi,et al.  Comparison of CT urography and excretory urography in the detection and localization of urothelial carcinoma of the upper urinary tract. , 2011, AJR. American journal of roentgenology.

[45]  L. Lacombe,et al.  Evaluation of fluorodeoxyglucose positron‐emission tomography with computed tomography for staging of urothelial carcinoma , 2010, BJU international.

[46]  B. Leibovich,et al.  Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. , 2010, The Journal of urology.

[47]  N. Rofsky,et al.  MR urography versus retrograde pyelography/ureteroscopy for the exclusion of upper urinary tract malignancy. , 2010, Clinical radiology.

[48]  K. Kihara,et al.  Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. , 2010, Urology.

[49]  Cary Siegel,et al.  Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  Y. Tokuda,et al.  The effects of neoadjuvant chemotherapy and chemo-radiation therapy on MRI staging in invasive bladder cancer: comparative study based on the pathological examination of whole layer bladder wall , 2009, International Urology and Nephrology.

[51]  S. Silverman,et al.  Bladder cancer detection with CT urography in an Academic Medical Center. , 2008, Radiology.

[52]  Adem Kiris,et al.  Detection of Bladder Tumors With 3‐Dimensional Sonography and Virtual Sonographic Cystoscopy , 2008, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[53]  Dalton A Anjos,et al.  18F-FDG PET/CT Delayed Images After Diuretic for Restaging Invasive Bladder Cancer , 2007, Journal of Nuclear Medicine.

[54]  M. Picchio,et al.  Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[55]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of surgery.

[56]  F. Millán-Rodríguez,et al.  Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups. , 2000, The Journal of urology.

[57]  A. Lembo,et al.  Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients. , 1999, Urology.

[58]  T. Kakizoe,et al.  Transitional cell carcinoma of the urethra in men following cystectomy for bladder cancer: multivariate analysis for risk factors. , 1991, The Journal of urology.

[59]  Adam T Froemming,et al.  Post-Treatment Surveillance of Bladder Cancer , 2019 .

[60]  O. Patschan,et al.  Fluorodeoxyglucose-positron emission tomography / computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer , 2017 .

[61]  M. Gil,et al.  Risk groups in bladder cancer patients treated with radical cystectomy , 2015, International braz j urol : official journal of the Brazilian Society of Urology.

[62]  T. Daskivich,et al.  Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancer. , 2015, Urologic oncology.

[63]  Ç. Dinçel,et al.  Patterns, risks and outcomes of urethral recurrence after radical cystectomy for urothelial cancer; over 20 year single center experience. , 2015, International journal of surgery.

[64]  F. Brimo,et al.  Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer. , 2014, Urologic oncology.

[65]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.